FDA Advisory Committee Recommends Approval of Paratek ’s Omadacycline

BOSTON, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) today announced that the Antimicrobials Drug Advisory Committee of the U.S. Food and Drug Administration voted in favor of the approval of intravenous (IV) and...
Source: Drugs.com - New Drug Applications - Category: Drugs & Pharmacology Source Type: news